8750 POSTER Bevacizumab Alone at 5 mg/kg in an Every-3-week Schedule for Patients With Recurrent Glioblastomas – a Single Center Experience
Kaloshi, G., Rroji, A., Bushati, T., Lame, A., Xhumari, A., Seferi, A., Petrela, M.Volume:
47
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(11)72301-2
Date:
September, 2011
File:
PDF, 39 KB
english, 2011